A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease

NCT00376168 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Gaucher Disease

Interventions

DRUG: Plant cell expressed recombinant glucocerebrosidase (prGCD)
DRUG: Plant cell expressed recombinant glucocerebrosidase (prGCD)

Sponsor

Pfizer